Cargando…
BTK suppresses myeloma cellular senescence through activating AKT/P27/Rb signaling
We previously explored the role of BTK in maintaining multiple myeloma stem cells (MMSCs) self-renewal and drug-resistance. Here we investigated the elevation of BTK suppressing MM cellular senescence, a state of irreversible cellular growth arrest. We firstly discovered that an increased expression...
Autores principales: | Gu, Chunyan, Peng, Hailin, Lu, Yue, Yang, Hongbao, Tian, Zhidan, Yin, Gang, Zhang, Wen, Lu, Sicheng, Zhang, Yi, Yang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593608/ https://www.ncbi.nlm.nih.gov/pubmed/28915637 http://dx.doi.org/10.18632/oncotarget.18096 |
Ejemplares similares
-
MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment
por: Gu, Chunyan, et al.
Publicado: (2015) -
Ginsenoside Rb2 suppresses cellular senescence of human dermal fibroblasts by inducing autophagy
por: Yang, Kyeong Eun, et al.
Publicado: (2023) -
Complete Genome Sequences of T4-Like Bacteriophages RB3, RB5, RB6, RB7, RB9, RB10, RB27, RB33, RB55, RB59, and RB68
por: Yaung, Stephanie J., et al.
Publicado: (2015) -
MK2 is a therapeutic target for high-risk multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2018) -
Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells
por: Bam, R, et al.
Publicado: (2014)